1.24
price down icon2.36%   -0.03
after-market Handel nachbörslich: 1.25 0.01 +0.81%
loading
Schlusskurs vom Vortag:
$1.27
Offen:
$1.27
24-Stunden-Volumen:
9.28M
Relative Volume:
1.12
Marktkapitalisierung:
$791.14M
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-3.875
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
-3.88%
1M Leistung:
-2.36%
6M Leistung:
-6.06%
1J Leistung:
-70.05%
1-Tages-Spanne:
Value
$1.21
$1.28
1-Wochen-Bereich:
Value
$1.21
$1.45
52-Wochen-Spanne:
Value
$1.09
$4.50

Geron Corp Stock (GERN) Company Profile

Name
Firmenname
Geron Corp
Name
Telefon
(650) 473-7700
Name
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Name
Mitarbeiter
229
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
GERN's Discussions on Twitter

Vergleichen Sie GERN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GERN
Geron Corp
1.24 835.80M 29.48M -201.19M -216.50M -0.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Geron Corp Stock (GERN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-10 Fortgesetzt Goldman Sell
2025-05-08 Herabstufung Scotiabank Sector Outperform → Sector Perform
2025-02-27 Herabstufung B. Riley Securities Buy → Neutral
2025-02-26 Herabstufung H.C. Wainwright Buy → Neutral
2024-11-05 Eingeleitet H.C. Wainwright Buy
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-09-09 Eingeleitet Leerink Partners Outperform
2024-04-30 Herabstufung Robert W. Baird Outperform → Neutral
2024-04-29 Eingeleitet TD Cowen Buy
2024-03-15 Bestätigt Needham Buy
2023-09-12 Hochstufung Goldman Neutral → Buy
2023-03-28 Eingeleitet Goldman Neutral
2022-10-28 Eingeleitet Wedbush Outperform
2022-07-28 Fortgesetzt B. Riley Securities Buy
2021-11-02 Eingeleitet Robert W. Baird Outperform
2021-02-18 Fortgesetzt B. Riley Securities Buy
2020-08-03 Eingeleitet Stifel Buy
2019-11-19 Fortgesetzt B. Riley FBR Buy
2019-09-03 Eingeleitet H.C. Wainwright Buy
2019-08-15 Eingeleitet Cantor Fitzgerald Overweight
2019-04-09 Hochstufung Needham Hold → Buy
2019-01-31 Hochstufung B. Riley FBR Neutral → Buy
2018-10-02 Herabstufung B. Riley FBR Buy → Neutral
2018-07-05 Eingeleitet B. Riley FBR, Inc. Buy
2016-09-13 Bestätigt FBR & Co. Outperform
2016-09-13 Bestätigt FBR Capital Outperform
2015-12-07 Bestätigt Piper Jaffray Overweight
2015-04-21 Eingeleitet Oppenheimer Outperform
2014-06-12 Hochstufung MLV & Co Hold → Buy
2014-03-12 Herabstufung MLV & Co Buy → Hold
2013-12-10 Bestätigt MLV & Co Buy
2013-12-10 Hochstufung Needham Hold → Buy
2013-11-08 Bestätigt MLV & Co Buy
2013-10-16 Eingeleitet MLV & Co Buy
2012-08-30 Eingeleitet Stifel Nicolaus Buy
2012-06-28 Eingeleitet Needham Hold
Alle ansehen

Geron Corp Aktie (GERN) Neueste Nachrichten

pulisher
08:25 AM

Geron Corp Announces Board and Executive Changes - TradingView

08:25 AM
pulisher
06:07 AM

Using data models to predict Geron Corporation stock movement2025 Market Trends & Detailed Earnings Play Alerts - newser.com

06:07 AM
pulisher
05:25 AM

How strong is Geron Corporation (GON) stock earnings growthTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com

05:25 AM
pulisher
04:11 AM

Geron (GERN): Assessing Valuation After Leadership Changes to Drive RYTELO Growth and Strategic Transformation - Yahoo Finance

04:11 AM
pulisher
Oct 13, 2025

Geron (GERN) Restructures Leadership with Key Executive Appointm - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

Geron (GERN) Announces Executive Leadership Changes to Boost Com - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

Geron announces leadership changes as part of strategic realignment - Investing.com

Oct 13, 2025
pulisher
Oct 13, 2025

Geron Corporation Announces Executive Leadership Transitions and Appointments - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

What earnings revisions data tells us about Geron CorporationSwing Trade & Risk Managed Investment Strategies - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

What makes Geron Corporation stock attractive to growth fundsBreakout Watch & High Return Trade Guides - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Is Geron Corporation (GON) stock undervalued at current priceQuarterly Profit Review & High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Combining machine learning predictions for Geron CorporationMarket Trend Summary & Risk Managed Trade Strategies - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Long term hold vs stop loss in Geron CorporationQuarterly Profit Summary & Verified Momentum Stock Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Why Geron Corporation (GON) stock gets analyst attentionMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Geron's (GERN) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)? - Yahoo Finance

Oct 08, 2025
pulisher
Oct 06, 2025

Geron (NASDAQ:GERN) Stock Price Down 4.8%Here's Why - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

Is Geron Corporation stock entering bullish territory2025 Investor Takeaways & Target Return Focused Picks - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is Geron Corporation (GON) stock ideal for retirement investorsGDP Growth & Reliable Intraday Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Analyzing recovery setups for Geron Corporation investorsWeekly Trend Report & AI Enhanced Execution Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What MACD trends signal for Geron Corporation (GON) stock2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Building trade automation scripts for Geron CorporationPrice Action & Risk Managed Investment Signals - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Several Insiders Invested In Geron Flagging Positive News - simplywall.st

Oct 02, 2025
pulisher
Oct 01, 2025

Geron Corp. Stock Hits Day High with Strong 7.87% Intraday Surge - Markets Mojo

Oct 01, 2025
pulisher
Sep 30, 2025

Geron (NASDAQ:GERN) Stock Price Up 4.2%Should You Buy? - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

Why institutional investors increase stakes in Geron Corporation (GON) stockPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Backtesting results for Geron Corporation trading strategies2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Sep 28, 2025
pulisher
Sep 23, 2025

Geron updates on Q4 revenue from U.S. sales of RYTELO - MSN

Sep 23, 2025
pulisher
Sep 18, 2025

Nearly 1M Shares: Geron Corporation's Major Equity Grant Package Draws 16 New Biotech Talents - Stock Titan

Sep 18, 2025
pulisher
Sep 18, 2025

Geron Corporation $GERN Shares Sold by Woodline Partners LP - MarketBeat

Sep 18, 2025
pulisher
Sep 15, 2025

Aug Volume: What analysts say about Geron Corporation stockJuly 2025 Rallies & Daily Profit Focused Stock Screening - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Geron Corporation $GERN Shares Purchased by Exome Asset Management LLC - MarketBeat

Sep 15, 2025

Finanzdaten der Geron Corp-Aktie (GERN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Geron Corp-Aktie (GERN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Samuels Scott Alan
EVP, Chief Legal Officer
Feb 27 '25
Buy
1.61
15,000
24,150
26,682
SCARLETT JOHN A
Chairman, President and CEO
Feb 27 '25
Buy
1.76
12,500
22,062
12,500
Ziegler James
EVP, Chief Commercial Officer
Feb 27 '25
Buy
1.60
100,000
160,000
100,000
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):